Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Anthem Biosciences

Market Cap: ₹425.5b

Operates as technology-focused contract research, development, and manufacturing organization.

Basilea Pharmaceutica

Market Cap: CHF 591.7m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Neuren Pharmaceuticals

Market Cap: AU$2.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Medpace Holdings

Market Cap: US$14.6b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Orion Oyj

Market Cap: €9.4b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Abbott India

Market Cap: ₹633.4b

Operates as a pharmaceutical company in India.

Xiamen Amoytop Biotech

Market Cap: CN¥31.6b

Engages in research, development, production, and sale of recombinant protein drugs in China.

ChemoMetec

Market Cap: DKK 11.7b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

SK Biopharmaceuticals

Market Cap: ₩7.9t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

GlaxoSmithKline Pakistan

Market Cap: PK₨136.4b

Operates as a biopharma company in Pakistan.

Torrent Pharmaceuticals

Market Cap: ₹1.2t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س11.2b

Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.

Blue Jet Healthcare

Market Cap: ₹113.3b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

Consun Pharmaceutical Group

Market Cap: HK$12.8b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Exelixis

Market Cap: US$10.6b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Catalyst Pharmaceuticals

Market Cap: US$2.5b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Waters

Market Cap: US$19.9b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Lotus Pharmaceutical

Market Cap: NT$78.8b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

BioArctic

Market Cap: SEK 26.5b

Develops biological drugs for patients with central nervous system disorders in Sweden.

Middle East Pharmaceutical Industries

Market Cap: ر.س2.7b

Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥46.8b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.

DHG Pharmaceutical

Market Cap: ₫13.3t

Engages in the manufacture and sale of pharmaceutical products in Vietnam.

ACADIA Pharmaceuticals

Market Cap: US$3.5b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Harmony Biosciences Holdings

Market Cap: US$1.5b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Shandong Wit Dyne HealthLtd

Market Cap: CN¥7.5b

Engages in the pharmaceutical business in China.

Incyte

Market Cap: US$17.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Hunan Jiudian Pharmaceutical

Market Cap: CN¥8.3b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

WuXi AppTec

Market Cap: CN¥284.6b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

Lupin

Market Cap: ₹885.6b

Operates as a pharmaceutical company in India, the United States, and internationally.

Genmab

Market Cap: DKK 129.0b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Gubra

Market Cap: DKK 6.6b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥30.2b

Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.

HBM Holdings

Market Cap: HK$10.7b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

NATCO Pharma

Market Cap: ₹148.0b

A pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.

CytomX Therapeutics

Market Cap: US$540.9m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Zealand Pharma

Market Cap: DKK 31.8b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.